These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 19015066)

  • 1. Origin of renal cell carcinomas.
    Valladares Ayerbes M; Aparicio Gallego G; Díaz Prado S; Jiménez Fonseca P; García Campelo R; Antón Aparicio LM
    Clin Transl Oncol; 2008 Nov; 10(11):697-712. PubMed ID: 19015066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetic basis of cancer of the kidney.
    Linehan WM; Walther MM; Zbar B
    J Urol; 2003 Dec; 170(6 Pt 1):2163-72. PubMed ID: 14634372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics and histopathologic features of adult distal nephron tumors.
    Polascik TJ; Bostwick DG; Cairns P
    Urology; 2002 Dec; 60(6):941-6. PubMed ID: 12475646
    [No Abstract]   [Full Text] [Related]  

  • 4. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of BHD in sporadic renal tumors.
    Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
    Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic features of renal cortical tumors.
    Tickoo SK; Gopalan A
    Urol Clin North Am; 2008 Nov; 35(4):551-61; v. PubMed ID: 18992609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alterations and histopathologic findings in familial renal cell carcinoma.
    Hansel DE
    Histol Histopathol; 2006 Apr; 21(4):437-44. PubMed ID: 16437389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer.
    da Silva NF; Gentle D; Hesson LB; Morton DG; Latif F; Maher ER
    J Med Genet; 2003 Nov; 40(11):820-4. PubMed ID: 14627671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal carcinogenesis: genotype, phenotype and dramatype.
    Hino O; Kobayashi T; Momose S; Kikuchi Y; Adachi H; Okimoto K
    Cancer Sci; 2003 Feb; 94(2):142-7. PubMed ID: 12708488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.
    Brauch H; Weirich G; Brieger J; Glavac D; Rödl H; Eichinger M; Feurer M; Weidt E; Puranakanitstha C; Neuhaus C; Pomer S; Brenner W; Schirmacher P; Störkel S; Rotter M; Masera A; Gugeler N; Decker HJ
    Cancer Res; 2000 Apr; 60(7):1942-8. PubMed ID: 10766184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary Renal Cancer Syndromes.
    Yanus GA; Kuligina ES; Imyanitov EN
    Med Sci (Basel); 2024 Feb; 12(1):. PubMed ID: 38390862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving understanding and surgical management of renal cortical tumors.
    Russo P
    Mayo Clin Proc; 2000 Dec; 75(12):1233-5. PubMed ID: 11126829
    [No Abstract]   [Full Text] [Related]  

  • 13. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.
    Foster K; Prowse A; van den Berg A; Fleming S; Hulsbeek MM; Crossey PA; Richards FM; Cairns P; Affara NA; Ferguson-Smith MA
    Hum Mol Genet; 1994 Dec; 3(12):2169-73. PubMed ID: 7881415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics of familial renal cell carcinoma syndromes.
    Cohen D; Zhou M
    Clin Lab Med; 2005 Jun; 25(2):259-77. PubMed ID: 15848736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
    Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
    Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series.
    Kennedy JM; Wang X; Plouffe KR; Dhanasekaran SM; Hafez K; Palapattu GS; Else T; Weizer AZ; Morgan TM; Spratt DE; Davenport MS; Chinnaiyan AM; Udager AM; Mehra R
    Med Oncol; 2019 Jul; 36(9):74. PubMed ID: 31332543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hippel-Lindau syndrome and sporadic renal cell carcinomas. Pathogenesis, morphologic spectrum and molecular genetics].
    Brauch H; Böhm J; Höfler H
    Pathologe; 1995 Sep; 16(5):321-7. PubMed ID: 7479604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutations of the MET proto-oncogene in papillary renal carcinomas.
    Schmidt L; Junker K; Nakaigawa N; Kinjerski T; Weirich G; Miller M; Lubensky I; Neumann HP; Brauch H; Decker J; Vocke C; Brown JA; Jenkins R; Richard S; Bergerheim U; Gerrard B; Dean M; Linehan WM; Zbar B
    Oncogene; 1999 Apr; 18(14):2343-50. PubMed ID: 10327054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy.
    Pfaffenroth EC; Linehan WM
    Expert Opin Biol Ther; 2008 Jun; 8(6):779-90. PubMed ID: 18476789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary Renal Cell Carcinoma Syndromes: Clinical, Pathologic, and Genetic Features.
    Adeniran AJ; Shuch B; Humphrey PA
    Am J Surg Pathol; 2015 Dec; 39(12):e1-e18. PubMed ID: 26559379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.